CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 86 filers reported holding CUREVAC N V in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,037,887 | -60.6% | 298,373 | -39.9% | 0.00% | -100.0% |
| Q2 2023 | $5,175,604 | +193.7% | 496,699 | +96.5% | 0.00% | – |
| Q1 2023 | $1,761,939 | +119.2% | 252,789 | +89.6% | 0.00% | – |
| Q4 2022 | $803,799 | -66.3% | 133,300 | -56.0% | 0.00% | – |
| Q3 2022 | $2,386,000 | -72.8% | 302,801 | -53.1% | 0.00% | -100.0% |
| Q2 2022 | $8,780,000 | -38.2% | 645,147 | -10.9% | 0.00% | +50.0% |
| Q1 2022 | $14,204,000 | -76.8% | 724,269 | -59.4% | 0.00% | 0.0% |
| Q4 2021 | $61,268,000 | +16.2% | 1,785,666 | +85.0% | 0.00% | -71.4% |
| Q3 2021 | $52,725,000 | -60.2% | 965,304 | -46.5% | 0.01% | -61.1% |
| Q2 2021 | $132,514,000 | +30.5% | 1,803,399 | +62.4% | 0.02% | +5.9% |
| Q1 2021 | $101,579,000 | +24.0% | 1,110,638 | +9.9% | 0.02% | +142.9% |
| Q4 2020 | $81,922,000 | +248.4% | 1,010,494 | +100.0% | 0.01% | +40.0% |
| Q3 2020 | $23,515,000 | – | 505,136 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,709,781 | $23,300,000 | 17.91% |
| Pinz Capital Management, LP | 40,200 | $547,000 | 0.38% |
| Parametrica Management Ltd | 13,513 | $184,000 | 0.20% |
| MQS Management LLC | 16,176 | $220,000 | 0.15% |
| Quantamental Technologies LLC | 11,552 | $157,000 | 0.07% |
| Ergoteles LLC | 98,100 | $1,335,000 | 0.04% |
| Virtus ETF Advisers LLC | 7,676 | $104,000 | 0.04% |
| Green Alpha Advisors, LLC | 12,247 | $167,000 | 0.04% |
| ETF MANAGERS GROUP, LLC | 53,789 | $746,000 | 0.02% |
| Quantbot Technologies LP | 14,800 | $201,000 | 0.02% |